Close×

Nescafe is asking consumers to join a capsule recycling program as part of National Recycling Week, running from 7- 11 November.

The coffee company's Dolce Gusto team has partnered with TerraCycle for the program, which will turn coffee, milk, tea, and chocolate capsules into planter boxes, playground equipment, and park benches.

“Capsule recycling requires a specific process that local council programs are currently unable to take on,” Nestlé Oceania's beverages GM Evan Gongolidis said.

“The program makes recycling simple and stress-free while giving not-for-profits a helping hand too.”
 
Since the program started in 2014, more than 10,000 consumers have recycled over half a million capsules.

TerraCycle extracts the coffee grounds and sends them to an industrial composting facility, while the plastic from each capsule is melted down and turned into pellets that can be used to make the recycled products.

The aluminium extracted from each capsule is also recycled.
 
Members select a charity or school to support, or nominate their own not-for-profit organisation or group to receive a donation on their behalf.
 
To date, members of the Nescafe Dolce Gusto Recycling Program have raised almost $10,000 for charities, not-for-profit organisations, and schools in Australia.

Food & Drink Business

Pure Wine Co has been appointed as the exclusive national mainland distributor for Tasmanian winery, Pipers Brook Vineyard. Effective from 1 March, Pure Wine Co will manage national mainland distribution and trade sales for Pipers Brook and its Kreglinger Sparkling, Pipers Tasmania and Ninth Island labels.

The fourth round of the federal government’s Traceability Grants Program is now open for applications, with funding from $50,000 to $500,000 available for projects modernising and enhancing agricultural traceability systems.

The rapid rise of GLP-1 weight loss medications is driving profound changes in consumer behaviour overseas – and Australia’s retail sector should prepare now. New data from Circana shows GLP-1 uptake has already reached meaningful scale in Australia, with 12 per cent of households reporting at least one member using a GLP-1 medication, as of September 2025.